In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tercica Inc.

Division of Ipsen
www.tercica.com

Latest From Tercica Inc.

Quite A Range: Adamas Ponders $10,000-$30,000 Price Tag For Gocovri

The US FDA approved the extended-release amantadine for levodopa-induced dyskinesia in Parkinson's disease. Adamas will finalize its pricing and begin selling the product later this year.

Approvals Launches

Ipsen's new NJ US HQ is home from home as France becomes 'difficult'

Ipsen achieved a milestone in its 10-month-old plan to double sales revenue by 2020 by focusing on specialty drug niches and expanding its global presence when the French biotechnology company opened its new US commercial headquarters on 25 April.

Metabolic Disorders Cancer

Ipsen Moves Aggressively On U.S. Strategy, Builds Out Commercial and R&D Infrastructure

As part of an ongoing strategic reorganization, Ipsen announced the appointment of a nine-member U.S. leadership team to execute on the growth of its neurology and endocrinology franchises.

North America Strategy

California's loss is New Jersey's gain in Ipsen US expansion move

As part of its strategy to increase its presence in the US, Paris drug maker Ipsen is moving its North American headquarters cross-country from California to New Jersey under a plan that also includes a $45 million expansion of its Massachusetts R&D and manufacturing facilities and the hiring of 117 new employees.

See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Metabolic Disorders
  • Alias(es)
  • Tercica Medica Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Ipsen
  • Senior Management
  • Contact Info
  • Tercica Inc.
    Phone: (650) 624-4900
    2000 Sierra Pt. Pkwy.
    Ste. 400
    Brisbane, CA 94005
    USA
UsernamePublicRestriction

Register